Zeige Ergebnisse 441 - 460 von 482
Ehlert, U., & Nater, U. M. (2006). Psychobiologische Forschungsperspektiven in der Verhaltensmedizin und ihr Beitrag zur Erklärung gestörter Entwicklung. in A. Remmel, O. F. Kernberg, W. Vollmoeller, & B. Strauss (Hrsg.), Körper und Persönlichkeit. Diagnostik und Therapie gestörter Entwicklung. (S. 117-123). Schattauer.
Nater, U. M., Gaab, J., Rief, W., & Ehlert, U. (2006). Recent trends in behavioral medicine. Current Opinion in Psychiatry, 19(2), 180-183. https://doi.org/10.1097/01.yco.0000214345.37002.77
Ehlert, U., Erni, K., Hebisch, G., & Nater, U. (2006). Salivary alpha-amylase levels after yohimbine challenge in healthy men. The Journal of clinical endocrinology and metabolism, 91(12), 5130-5133. https://doi.org/10.1210/jc.2006-0461
Nater, U. M., & Ehlert, U. (2006). Stressabhängige körperliche Störungen. in H-U. Wittchen, & J. Hoyer (Hrsg.), Lehrbuch Klinische Psychologie und Psychotherapie (S. 871-881). Springer.
König, D., Jagsch, R., Kryspin-Exner, I., & Koriska, K. (2006). Subjective vs. objective health-ratings - concordances or discrepancies? Psychology & Health, 21(Suppl. 1), 82-82.
Jagsch, R., & Pils, K. (2006). Which instrument is more suitable to assess health-related quality of life: Nottingham Health Profile or Short-Form-36? Wiener Medizinische Wochenschrift, 156(5-6), 149-157. https://doi.org/10.1007/s10354-006-0266-9
Nater, U. M., Krebs, M., & Ehlert, U. (2005). Sensation seeking, music preference, and psychophysiological reactivity to music. Musicae Scientiae, 9(2), 239-254. https://doi.org/10.1177/102986490500900205
Ehlert, U., Nater, U. M., & Böhmelt, A. (2005). High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. Journal of Psychosomatic Research , 59(1), 7-10. https://doi.org/10.1016/j.jpsychores.2005.03.005
Gaab, J., Rohleder, N., Nater, U. M., & Ehlert, U. (2005). Psychological determinants of the cortisol stress response: the role of anticipatory cognitive appraisal. Psychoneuroendocrinology, 30(6), 599-610. https://doi.org/10.1016/j.psyneuen.2005.02.001
Böhmelt, A. H., Nater, U. M., Franke, S., Hellhammer, D. H., & Ehlert, U. (2005). Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Journal of Psychosomatic Research , 67(2), 288-294. https://doi.org/10.1097/01.psy.0000157064.72831.ba
Jagsch, R., Primorac, A., Ebner, N., & Fischer, G. (2005). Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction, 100(8), 1101-1109. https://doi.org/10.1111/j.1360-0443.2005.001128.x
Jagsch, R., Prechtl, V., Watzinger, F., & Hollmann, K. (2005). Evaluation of esthetic, functional, and quality-of-life outcome in adult cleft lip and palate patients. Cleft Palate - Craniofacial Journal: Official Publication of the American Cleft Palate-Craniofacial Association, 42(4), 355-361. http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-22244432172&partnerID@&rel=R5.6.0
Nater, U. M., Rohleder, N., Gaab, J., Berger, S., Jud, A., Kirschbaum, C., & Ehlert, U. (2005). Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. International Journal of Psychophysiology, 55(3), 333-342. https://doi.org/10.1016/j.ijpsycho.2004.09.009
Jagsch, R., Schindler, S-D., Moody, D. E., & Fischer, G. (2005). Opioid plasma concentrations in methadone- and buprenorphine-maintained patients. Addiction Biology, 10(4), 365-371. http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-28744459340&partnerID@&rel=R5.6.0
Pemberger, S., Jagsch, R., Frey, E., Felder-Puig, R., Kryspin-Exner, I., & Topf, R. J. (2005). Quality of life in long-term childhood cancer survivors and the relation of late effects and subjective well-being. Supportive Care in Cancer, 13(1), 49-56. http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-13244283170&partnerID@&rel=R5.6.0
Kraigher, D., Jagsch, R., Gombas, W., Ortner, R., Eder, H., Primorac, A., & Fischer, G. (2005). Use of slow-release oral morphine for the treatment of opioid dependence. European Addiction Research, 11(3), 145-151. https://doi.org/10.1159/000085550
Heinrichs, M., Nater, U. M., & Ehlert, U. (2004). Biopsychologische Modelle von Gesundheit und Krankheit. in B. Strauß, U. Berger, J. von Troschke, & E. Brähler (Hrsg.), Lehrbuch Medizinische Psychologie und Medizinische Soziologie (S. 61-77). Hogrefe.
Ortner, R., Jagsch, R., Primorac, A., & Fischer, G. (2004). Buprenorphine maintenance: Office-based treatment with addiction clinic support. European Addiction Research, 10(3), 105-111. https://doi.org/10.1159/000077698
Haasen, C., Prinzleve, M., Zurhold, H., Rehm, J., Güttinger, F., Fischer, G., Jagsch, R., Olsson, B., Ekendahl, M., Verster, A., Camposeragna, A., Pezous, A. M., Gossop, M. R., Manning, V., Cox, G., Ryder, N., Gerevich, J., Bacskai, E., Casas, M., ... Krausz, M. (2004). Cocaine use in Europe - A multi-centre study: Methodology and prevalence estimates. European Addiction Research, 10(4), 139-146. https://doi.org/10.1159/000079834
Stetina, B., Jagsch, R., & Kryspin-Exner, I. (2004). Prävention, Information und Internet. Einstellungen von Ecstasy-Usern - eine Online-Studie. in Gesundheit - Risiko, Chancen und Herausforderung: VI. Kongress für Gesundheitspsychologie 25. - 27. März Leipzig - Tagungsband (S. 47-47). Unknown publisher.
Zeige Ergebnisse 441 - 460 von 482